rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2000-4-21
|
pubmed:abstractText |
The management of CSF rhinorrhoea following dopamine agonist (DA) treatment for invasive prolactinomas is difficult and there is no clear consensus for its treatment. Our objective was therefore to investigate the different treatments for this condition.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0300-0664
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
43-9
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:10651752-Adult,
pubmed-meshheading:10651752-Bromocriptine,
pubmed-meshheading:10651752-Cerebrospinal Fluid Rhinorrhea,
pubmed-meshheading:10651752-Dopamine Agonists,
pubmed-meshheading:10651752-Ergolines,
pubmed-meshheading:10651752-Female,
pubmed-meshheading:10651752-Humans,
pubmed-meshheading:10651752-Magnetic Resonance Imaging,
pubmed-meshheading:10651752-Male,
pubmed-meshheading:10651752-Middle Aged,
pubmed-meshheading:10651752-Pituitary Neoplasms,
pubmed-meshheading:10651752-Prolactinoma,
pubmed-meshheading:10651752-Tomography, X-Ray Computed
|
pubmed:year |
2000
|
pubmed:articleTitle |
CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas.
|
pubmed:affiliation |
University Clinical Department of Diabetes and Endocrinology, University Hospital Aintree, Liverpool, UK. leongk@liv.ac.uk
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports
|